About Us
Company Overview
Vision / Mission / Values
Leadership
Clinical Advisory Board
Partnering
Our Approach
Technologies
Manufacturing
Publications
Pipeline
Pipeline
CAR T-cell therapies
mAb
Expanded Access
Investors
Announcements
Corporate Governance
Corporate Deck & Presentations
Webcasts
Presentations
Financial Reports
Listing Documents
IR Contact
Newsroom
Careers
Join Us
Contact Us
EN
简
About Us
Company Overview
Vision / Mission / Values
Leadership
Clinical Advisory Board
Partnering
Our Approach
Technologies
Manufacturing
Publications
Pipeline
Pipeline
CAR T-cell therapies
mAb
Expanded Access
Investors
Announcements
Corporate Governance
Corporate Deck & Presentations
Webcasts
Presentations
Financial Reports
Listing Documents
IR Contact
Newsroom
Careers
Join Us
Contact Us
Publication
Home
-
Our Approach
-
Oncotarget
May 16, 2017
Treatment of hepatocellular carcinoma with a GPC3-targeted bispecific T cell engager
Yanyu Bi,*, Hua Jiang,*, Peng Wang, Bo Song, Huamao Wang, Xianming Kong, Zonghai Li
Cancer Immunol,Immunother
Dec 29, 2016
Development of T cells carrying two complementary chimeric antigen receptors against glypican‑3 and asialoglycoprotein receptor 1 for the treatment of hepatocellular carcinoma
Cheng Chen, Kesang Li, Hua Jiang, Fei Song,Huiping Gao, Xiaorong Pan ·Bizhi Shi, Yanyu Bi,Huamao Wang, Hongyang Wang, Zonghai Li
1
3
4
